tiprankstipranks
Fresenius SE & Co (FSNUY)
OTHER OTC:FSNUY
Holding FSNUY?
Track your performance easily

Fresenius SE & Co (FSNUY) Earnings Dates, Call Summary & Reports

86 Followers

Earnings Data

Report Date
Mar 26, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
$0.17
Last Year’s EPS
$0.19
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 06, 2024
|
% Change Since: -3.47%
|
Next Earnings Date:Mar 26, 2025
Earnings Call Sentiment|Positive
Fresenius demonstrated strong financial performance and growth across key segments, particularly Kabi and Helios. However, challenges remain with the continued softness in China and the end of energy relief funding impacting Helios. The company's upgraded guidance reflects confidence in its performance, but interest expenses pose a future risk.
Company Guidance
During the Q3 2024 earnings call for Fresenius (FRE.DE), the company's executives provided an optimistic outlook, highlighting significant improvements across various financial metrics. The guidance for the remainder of 2024 was upgraded, with expectations for organic revenue growth set between 6% to 8% and EBIT growth projected at 8% to 11%. In Q3, the company achieved a robust 9% organic revenue increase, reaching EUR 5.3 billion, and a 9% rise in EBIT to EUR 552 million. Cash flow generation was strong, with Fresenius producing over EUR 760 million in operating cash flow and reducing its net debt-to-EBITDA ratio to 3.24x. The Kabi division posted an impressive 11% organic revenue growth, driven by its biopharma segment, which saw a 66% increase. Helios also performed well, with an 8% rise in organic revenue. Despite challenges in China, the company remains confident in its strategic initiatives, particularly emphasizing structural productivity improvements and innovation, bolstering its competitive position in the healthcare sector.
Strong Financial Performance
Fresenius reported high single-digit organic revenue and earnings growth with a 9% increase in group organic revenue and a 9% rise in EBIT before special items. Operating cash flow reached over EUR 760 million, and the company continued to lower leverage, ending the quarter at 3.24x net debt to EBITDA.
Kabi Segment Success
Kabi's revenue grew organically by 11% year-on-year, driven by strong performance in biopharma with a 66% increase. Kabi's EBIT margin improved to 15.9%, a significant year-over-year margin improvement of 160 basis points.
Helios Revenue Growth
Helios reported an 8% organic revenue growth, with Helios Germany achieving an 8% growth and a margin of 8.8%. Year-to-date, Helios Spain delivered a strong margin of 11.2%.
Upgraded Financial Outlook
Fresenius upgraded its guidance, now expecting 6% to 8% organic revenue growth and 8% to 11% EBIT growth for the full year 2024.
---

Fresenius SE & Co (FSNUY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

FSNUY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 26, 20252024 (Q4)
0.17 / -
0.189
Nov 06, 20242024 (Q3)
0.18 / 0.18
0.16214.20% (+0.02)
Jul 31, 20242024 (Q2)
0.19 / 0.22
0.18517.84% (+0.03)
May 08, 20242024 (Q1)
0.19 / 0.20
0.1897.94% (+0.01)
Feb 21, 20242023 (Q4)
0.20 / 0.19
0.211-10.43% (-0.02)
Nov 02, 20232023 (Q3)
0.16 / 0.16
0.17-4.71% (>-0.01)
Aug 02, 20232023 (Q2)
0.17 / 0.18
0.203-8.87% (-0.02)
May 09, 20232023 (Q1)
0.17 / 0.19
0.219-13.70% (-0.03)
Feb 22, 20232022 (Q4)
0.23 / 0.21
0.266-20.68% (-0.06)
Oct 30, 20222022 (Q3)
0.17 / 0.17
0.226-24.78% (-0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

FSNUY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2024$9.22$9.32+1.08%
Jul 31, 2024$8.62$8.98+4.18%
May 08, 2024$7.58$7.65+0.92%
Feb 21, 2024$7.05$7.08+0.43%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Fresenius SE & Co (FSNUY) report earnings?
Fresenius SE & Co (FSNUY) is schdueled to report earning on Mar 26, 2025, TBA Not Confirmed.
    What is Fresenius SE & Co (FSNUY) earnings time?
    Fresenius SE & Co (FSNUY) earnings time is at Mar 26, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is FSNUY EPS forecast?
          FSNUY EPS forecast for the fiscal quarter 2024 (Q4) is $0.17.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis